Evidence map›Paper›PMID 40881759›Full record

ReviewWorld journal of transplantation2025

Incidence, screening, and management of

Anmol Singh, Carol Singh, Armaan Dhaliwal, Navdeep Singh, Vikash Kumar, Aalam Sohal, Jonathan Schneider

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in World journal of transplantation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. [Novel research horizon for liver transplantation management model in hepatocellular carcinoma based on the tumor-donor liver-recipient].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Anmol SinghDepartment of Medicine, Tristar Centennial Medical Center, Nashville, TN 37203, United States.
Carol SinghDepartment of Medicine, Dayanand Medical College and Hospital, Ludhiana 141001, Punjab, India.
Armaan DhaliwalDivision of Hematology and Oncology, Lehigh Valley Health Network, Allentown, PA 18103, United States.
Navdeep SinghDepartment of Medicine, Government Medical College, Amritsar 143001, Punjab, India.
Vikash KumarDivision of Gastroenterology, Creighton University School of Medicine, Phoenix, AZ 85012, United States.
Aalam SohalDivision of Gastroenterology, Creighton University School of Medicine, Phoenix, AZ 85012, United States. aalamsohal@gmail.com.
Jonathan SchneiderDivision of Gastroenterology, Tristar Centennial Medical Center, Nashville, TN 37203, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Liver transplantation (LT) is the definitive treatment for end-stage liver disease, acute liver failure, and liver cancer. Although advancements in surgical techniques, postoperative care, and immunosuppressive therapies have significantly improved outcomes, the long-term use of immunosuppression has increased the risk of complications, including infections, cardiovascular disease, and cancer. Among these,

Indexed as

De novo malignancyImmunosuppressionLiver transplantPost-transplant lymphoproliferative disorderScreeningSquamous cell cancer

Identifiers

PMID40881759
PMCPMC12038579

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.